Research Article
Genome-Wide and Gene-Specific Epigenomic Platforms for Hepatocellular Carcinoma Biomarker Development Trials
Table 1
Hepatocellular carcinoma risk factors per participant.
| ID | Age | Sex | Race | Type | Etiology | Histology | Size | AFP | B4GALT1 | RASSF1A | SSBP2 |
| 16 | 53 | M | W | Normal | Cryptogenic | Cirrhosis | · | · | U | U | U | 22 | 58 | M | W | Normal | HCV | Cirrhosis | · | · | U | U | U | 30 | 65 | M | W | Normal | HCV | Cirrhosis | · | · | U | U | U | 31 | 67 | M | W | Normal | HCV | Cirrhosis | · | · | U | M | M | 21 | 58 | M | W | Normal | Other | Cirrhosis | · | · | U | U | U | 15 | 50 | F | B | Normal | Cryptogenic | Noncirrhotic | · | · | U | U | U | 2 | 19 | F | B | Normal | HCV | Noncirrhotic | · | · | U | U | M | 29 | 62 | F | W | Normal | HCV | Noncirrhotic | · | · | U | U | U | 9 | 40 | F | B | Normal | Other | Noncirrhotic | · | · | U | U | U | 4 | 26 | F | W | Normal | Other | Noncirrhotic | · | · | U | U | M | 13 | 45 | F | W | Normal | Other | Noncirrhotic | · | · | U | U | U | 35 | 81 | F | W | Normal | Other | Noncirrhotic | · | · | U | M | U | 18 | 54 | M | B | Normal | Cryptogenic | Noncirrhotic | · | · | U | U | U | 10 | 42 | M | W | Normal | Other | Noncirrhotic | · | · | U | M | U | 20 | 55 | M | W | Normal | Other | Noncirrhotic | · | · | U | M | M | 36 | unk | unk | unk | Normal | unk | unk | · | · | U | U | M | 37 | unk | unk | unk | Normal | unk | unk | · | · | U | U | U | 38 | unk | unk | unk | Normal | unk | unk | · | · | U | U | M | 39 | 53 | M | M | Normal | ETOH | Noncirrhotic | · | · | U | U | U | 40 | 19 | F | F | Normal | HCV | Noncirrhotic | · | · | U | U | U | 41 | 57 | M | M | Normal | HCV | Cirrhosis | · | · | U | U | U | 42 | 60 | M | M | Normal | HCV | Cirrhosis | · | · | U | U | U | 5 | 28 | F | W | Tumor | Other | HCC | 2.5 | 1 | M | U | U | 28 | 62 | F | W | Tumor | HCV | HCC | 2.8 | 17 | U | M | M | 17 | 53 | M | W | Tumor | Cryptogenic | HCC | 4 | 10 | U | M | U | 7 | 40 | F | B | Tumor | Other | HCC | 3.7 | 1 | U | U | M | 25 | 59 | F | AS | Tumor | HBV | HCC | 4 | 20 | M | M | M | 3 | 20 | F | W | Tumor | HCV | HCC | 4 | unk | M | U | U | 27 | 60 | M | B | Tumor | HCV/ETOH | HCC | 4 | 20 | M | M | M | 11 | 45 | M | W | Tumor | HCV | HCC | 5.0 | unk | M | M | M | 8 | 40 | M | W | Tumor | HCV | HCC | 5.5 | 11110 | U | U | U | 32 | 67 | M | W | Tumor | HCV | HCC | 6 | 2 | M | M | M | 33 | 73 | M | W | Tumor | Other | HCC | 6 | 2 | U | M | M | 6 | 37 | M | B | Tumor | Other | HCC | 7.0 | 54071 | U | M | U | 23 | 58 | M | W | Tumor | Other | HCC | 7.2 | 4659 | M | U | M | 14 | 50 | F | B | Tumor | Cryptogenic | HCC | 9 | 1594 | U | M | U | 26 | 60 | M | W | Tumor | Cryptogenic | HCC | 12 | 146 | M | M | M | 19 | 55 | M | W | Tumor | Other | HCC | 17 | 5 | U | M | M | 12 | 45 | F | B | Tumor | HVB/HCV | HCC | unk | unk | U | U | U | 24 | 58 | M | W | Tumor | HCV | HCC | unk | unk | M | M | M | 1 | 19 | F | B | Tumor | HCV | HCC | 25 | 19764 | U | M | M | 34 | 74 | F | W | Tumor | Cryptogenic | HCC | 4.5 | unk | M | M | U | 43 | 42 | M | M | Tumor | Other | HCC | 15 | NA | M | M | U | 44 | 26 | F | M | Tumor | Other | HCC | 8 | NA | M | M | U | 45 | 12 | F | M | Tumor | Other | HCC | NA | NA | M | M | U | 46 | NA | NA | NA | Tumor | NA | HCC | NA | NA | U | M | U | 47 | NA | NA | NA | Tumor | NA | HCC | NA | NA | U | M | M | 48 | NA | NA | NA | Tumor | NA | HCC | NA | NA | U | U | M | 49 | 45 | F | F | Tumor | Cryptogenic | HCC | 1.5 | NA | M | M | M |
|
|
M: Methylated; U: Unmethylated; unk: unknown.
|